- 韩国限量
- 0.08%
产品中实际含有多少
暂无产品标示该成分含量。
含该成分的产品中，14 款将其列在 1% 线之前，14 款列在之后（通常不超过 1%）。
含有此成分的产品
已确认 28 款中的 12 款 · 按含量充足程度排序 · 查看全部 28 款
PUREDERMGreen Tea Cleansing Tissue
PUREDERMCucumber Cleansing Tissue
AriulThe Perfect Tissue Plus 20 Sheets
AriulStress Relieving Pureful Cleansing Tissue, 80 Sheets, 1 Pack
CREMORLABT.E.N Cremor® Cleansing Veil 70 Sheets
AriulAriul Stress Relieving Purefull Cleansing Tissue 15 Sheets
AriulAriul Stress Relieving Purefull Cleansing Tissue 80 Sheets
CREMORLABCremorlab T.E.N Cremor® Cleansing Veil 10 Sheets
CREMORLABCremorlab T.E.N Cremor® Cleansing Veil 70 Sheets
Banila CoBanila Co Clean It Zero Soothing Lip & Eye Remover Pad 30pcs
AriulAriul Stress Relieving Daily Pick Toning Pad 30 Sheets
AriulAriul Stress Relieving Daily Pick Peeling Pad 30 Sheets
定义
Cetylpyridinium Chloride is a quaternary ammonium salt that conforms generally to the formula
化妆品中的作用
减少静电ANTISTATIC护理口腔ORAL CARE抑制微生物生长ANTIMICROBIAL减少体味DEODORANT
安全与法规参考
日本
- 每100g最大配合量 (Cosmetics not used for mucosa and to be washed away) : 5.0 g
- 每100g最大配合量 (Cosmetics not used for mucosa and not to be washed away) : 1.0 g
- 每100g最大配合量 (Cosmetics that may be used for mucosa) : 0.010 g
韩国
- 最大配合量 : 0.08%
来源: 韩国食药处 化妆品法规信息
Other restriction: ban substances that deplete the ozone layer · SCCS opinion: Opinion on Cetylpyridinium chloride; Opinion on Cetylpyridinium chloride - Submission II
来源: 欧盟 CosIng 成分清单
详细资料——标示名称、识别编号、物性、试验记录、文献
官方标示名称和定义
日本化妆品工业联合会标示名称 セチルピリジニウムクロリド: 本品は、次の化学式で表される４級アンモニウム塩である。
来源: 日本化妆品工业联合会标示名称
别名和识别信息
CETYLPYRIDINIUM CHLORIDEINCI세틸피리디늄클로라이드韩国标示名称（食药处标准名）セチルピリジニウムクロリド日本标示名称
相关文献
- Study of the Pharmacokinetics, Tolerability, and Safety of Fixed-Dose Combinations of Gramicidin S and Cetylpyridinium Chloride · 2025
- [Results of a clinical study of the combination of flurbiprofen and cetylpyridinium chloride in patients with sore throat]. · 2022
- [Results of the clinical study of the combination of flurbiprofen and cetylpyridinium chloride in patients with sore throat]. · 2022
- Cetylpyridinium chloride as a part of a combined medication for adults and children during the COVID-19 pandemic: established and perspective use · 2021
- Formulation and characterization of cetylpyridinium chloride bioadhesive tablets. · 2014